Chiral ionic liquids bearing O-silylated α,α-diphenyl (S)- Or (R)-prolinol units: Recoverable organocatalysts for asymmetric michael addition of nitroalkanes to α,β-enals

European Journal of Organic Chemistry

Volumn , Issue 15, 2010, Pages 2927-2933

  Maltsev, Oleg V ^a,b   Kucherenko, Alexandr S ^a   Beletskaya, Irina P ^c   Tartakovsky, Vladimir A ^a   Zlotin, Sergei G ^a  

^a N D ZELINSKY INSTITUTE OF ORGANIC CHEMISTRY   (Russian Federation)

^b MENDELEEV UNIVERSITY OF CHEMICAL TECHNOLOGY OF RUSSIA   (Russian Federation)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

Author keywords

Asymmetric catalysis; Ionic liquids; Michael addition; Organocatalysis; Supported catalysts

Indexed keywords

EID: 77952201735     PISSN: 1434193X     EISSN: 10990690     Source Type: Journal    
DOI: 10.1002/ejoc.201000239     Document Type: Article

References (92)

1. a) J. G. Hardman, L. E. Limbird, G. A. Gilman (Eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics, 10th ed., McGraw-Hill, New York, 2001, section III;
2. b) P. L. McGeer, E. G. McGeer in Basic Neuro chemistry: Molecular, Cellular and Medical Aspects (Eds.: G. J. Siegel, B. Agranoff, R. W Albens, P. Molinoff), 4th ed., Raven, New York, 1989.
3. P. Krogsgaard-Larsen, J. Scheel-Krueger, H. Kofod (Eds.), GABA-Neurotransmitters. Pharmacoehemical, Biochemical and Pharmacological Aspects, Munksgaard, Copenhagen, 1979.
4. V. E. Shashoua, J. N. Jacob, R. Ridge, A. Campbell, R. J. Baldessarini, J. Med, Chem. 1984, 27, 659-664.
5. a) G. Costantino, A. Macchiarulo, A. E. Guadix, R. Pellicciari, J. Med. Chem. 2001, 44, 1827-1832;
6. b) D. I. B. Kerr, J. Ong, Drug Discovery Today 1996, 7, 371-380;
7. c) W Froestl, N. G. Cooke, S. J. Mickel in The Receptors: The GABA Receptors (Eds.: S. J. Enna, H. Monier), 3rd ed., Humana Press Inc., Totowa, 2007, pp. 239-251.
8. a) H. R. Olpe, H. Demieville, V. Baltzer, W L. Bencze, W. P. Koella, P. Wolf, H. L. Haas, Eur. J. Pharmacol. 1978, 52, 133-136;
9. b) N. G. Bowery, D. R. Hill, A. L. Hudson, Neuropharmacology 1985, 24, 207-210;
10. c) N. G. Bowery, A. L. Hudson, G. W Price, Neuroscience 1987, 20, 365-383;
11. d) S. Shuto, N. Snibuty, S. Yamada, T. Ohkura, R. Kirnura, A. Matsuda, Chem. Pharm. Bull. 1999, 47, 1188-1192.
12. a) D. E. Griswold, E. F. Webb, J. Breton, J. R. White, P. J. Marshall, T.J. Torphy, Inflammation 1993, 17, 333-344;
13. b) H. Wachtel, Neuropharmacology 1983, 22, 267-272;
14. c) S. J. Kanes, J. Tokarczyk, S. J. Siegel, W Bilker, T. Abel, M. P. Kelly, Neuroscience 2007, 144, 239-246;
15. d) Z. Lelkes, P. Alloldi, A. Erd'S, G. Benedek, Pharmacol. Biochem. Behav. 1998, 60, 835-839.
16. a) L. J. Crofford, M. C. Rowbotham, P. J. Mease, J. I. Russell, R. H. Dworkin, A. E. Corbin, J.P. Young Jr., L. K. LaMoreaux, S. A. Martin, U. Sharma, Arthritis & Rheumatism 2005, 52, 1264-1273;
17. b) P. J. Siddall, M. J. Cousins, A. Otte, T. Griesing, R. Chambers, T. K. Murphy, Neurology 2006, 67, 1792-1800;
18. c) R. H. Dworkin, P. Kirkpatrick, Nat. Rev. Drug Discov-ery 2005, 4, 455-456.
19. a) I. Lapin, CNS Drug Rev. 2001, 7, 471-4181;
20. b) J. Ong, D. J.. S. Kerr, D. J. Doolette, R. K. Duke, K. N. Mewett, R. D. Allen, G. A. R. Johnston, Eur. J. Pharmacol. 1993, 233, 169-172;
21. c) I. A. Sytinsky, A. T. Soldatenkov, A. Lajtha, Prog. Neurobiol. 1978, 10, 89-96.
22. For more active (R)-Rolipram, see: a.) Ch. A. Parker, J. C. Matthews, R. N. Gunn, L. Martarello, V. J. Cunningham, D. Dommett, S. T. Knibb, D. Bender, S. Jakobsen, J. Brown, A. D. Gee, Synapse 2005, 55, 270-279; for more active (R)-Balcofen, see:
23. b) D. F. Smith, J. Neural Transmission 1984, 60, 63-67; for more active (S)-Pregabalin, see:
24. c) J. E. Frampton, R. H. Foster, CNS Drugs 2006, 20, 685-693; for more active (R)-Phenibut, see:
25. d) M. Dambrova, L. Zvejniece, E. Liepinsh, H. Cirule, O. Zharkova, G. Veinberg, I. Kalvinsh, Eur. J. Pharm. 2008, 583, 128-134.
26. a) F. Felluga, V. Gombac, G. Pitacco, E. Valentin, Tetrahedron: Asymmetry 2005, 16,1341-1345;
27. b) C. Mazzini, J. Lebreton, V. Alphand, R. Furstoss, Tetrahedron Lett. 1997, 38, 1195-1196;
28. c) E. Brenna, N. Caraccia, C. Fuganti, D. Fuganti, P. Grasselli, Tetrahedron: Asymmetry 1997, 8, 3801-3805;
29. d) R. Chenevert, M. Desjardins, Can. J.chem. 1994, 72, 2312-2317.
30. a) M. Hayashi, K. Ogasawara, Heterocycles 2003, 59, 785-791;
31. b) S. Yoshifuji, M. Kaname, Chem. Pharm. Bull. 1995, 43, 1302-1306;
32. c) C. Herdeis, H. P. Hubmann, Tetrahedron: Asymmetry 1992, 3, 1213-1221;
33. d) A. Armstrong, N. J. Convine, M. E. Popkin, Synlett 2006, 1589-1591;
34. e) D. Enders, O. Niemeier, Heterocycles 2005, 66, 385-403;
35. f) P. Camps, D. MunozTorrero, L. Sanchez, Tetrahedron: Asymmetry 2004, 15, 2039-2044;
36. g) E. Licandro, S. Maiorana, C. Baldoli, L. Capella, D. Perdicchia, Tetrahedron: Asymmetry 2000, 11, 975-980;
37. h) P. Resende, W. P. Almeida, F. Coelho, Tetrahedron: Asymmetry 1999, 10, 2113-2118;
38. i) N. Langlois, N. Dahuron, H.-S. Wang, Tetrahedron 1996, 52, 15117-15126;
39. j) A. Schoenfelder, A. Mann, S. Le Coz, Synlett 1993, 1, 63-65;
40. k) S. Bellemin-Laponnaz, J. Tweddell, J. C. Ruble, F. M. Breitling, G. C. Fu, Chem. Commun. 2000, 1009-1011.
41. a) A. S. Paraskar, A. Sudalai, Tetrahedron 2006, 62, 4907-4916;
42. b) T. Nemoto, L. Jin, H. Nakamura, Y. Hamada, Tetrahedron Lett. 2006, 47, 6577-6581;
43. c) J.-M. Becht, O. Meyer, G. Heimchen, Synthesis 2003, 18, 2805-2811;
44. d) O. Belda, S. Lundgren, C. Moberg, Org. Lett. 2003, 5, 2275-2278;
45. e) V. V. Thakur, M. D. Nikalje, A. Sudalai, Tetrahedron: Asymmetry 2003, 14, 581-586;
46. f) M. P. Doyle, W.-H. Hu, Chirality 2002, 14, 169-172;
47. g) C. Baldoli, S. Maiorana, E. Licandro, D. Perdicchia, B. Vandoni, 'Tetrahedron: Asymmetry 2000, 11, 2007-2014.
48. a) T. Okino, Y. Hoashi, T. Furukawa, X. Xu, Y. Takemoto, J. Am. Chem. Soc. 2005, 127, 119-125;
49. b) E.J. Corey, F.-Y. Zhang, Org. Lett. 2000, 2, 4257-4259;
50. c) P. Garcia-Garcia, A. Ladepeche, R. Halder, B. List, Angew. Chem. Int. Ed. 2008, 47, 4719-1721;
51. d) Y. Hayashi, T. Itoh, M. Ohkubo, H. Ishikawa, Angew. Chem. Int. Ed. 2008, 47, 4722-4724;
52. e) Y. Chi, L. Guo, N. A. Kopf, S. H. Gellman, J. Am. Chem. Soc. 2008, 130, 5608-5609;
53. f) J. Vesely, G.-L. Zhao, A. Bartoszewicz, A. Córdova, Tetrahedron Lett. 2008, 49, 4209-1212;
54. g) B. Vakulya, S. Varga, T. Soós, J. Org. Chem. 2008, 73, 3475-3480;
55. h) P. S. Hynes, P.A. Stupple, D. J. Dixon, Org. Lett. 2008, 10, 1389-1391;
56. i) L. Ji, Y. Ma, J. Li, L. Zhang, L. Zhang, Tetrahedron Lett. 2009, 50, 6166-6168.
57. C. Palomo, A. Landa, A. Mielgo, M. Oiarbide, A. Puente, S. Vera, Angew. Chem. Int. Ed. 2007, 46, 8431-8435.
58. L. Zu, H. Xie, H. Li, J. Wang, W Wanga, Adv. Synth. Catal. 2007, 349, 2660-2664.
59. H. Gotoh, H. Ishikawa, Y. Hayashi, Org. Lett. 2007, 9, 5307-5309.
60. Y. Wang, P. Li, X. Liang, T. Y. Zhang, J. Ye, Chem. Commun. 2008, 1232-1234.
61. a) M. Gruttadauria, F. Giacalone, R. Noto, Chem. Soc. Rev. 2008, 37, 1666-1688;
62. b) M. Lombardo, C. Trombini, ChemCat-Chem 2010, 2, 135-145.
63. a) P. Li, L. Wang, M. Wang, Y. Zhang, Eur. J. Org. Chem. 2008, 1157-1160;
64. b) E. Alza, X.C. Cambeiro, C. Jimeno, M. A. Pericàs, Org. Lett. 2007, 9, 3717-3720;
65. c) Y-B. Zhao, L.W. Zhang, L.-Y. Wu, X. Zhong, R. Li, J.-T. Ma, Tetrahedron: Asymmetry 2008, 19, 1352-1355;
66. d) M. C. Varela, S. M. Dixon, K. S. Lam, N. E. Schore, Tetrahedron 2008, 64, 10087-10090;
67. e) E. Alza, M. A. Pericàs, Adv. Synth. Catal. 2009, 351, 3051-3056.
68. a) L. Tuchman-Shukrona, M. Portnoy, Adv. Synth. Catal. 2009, 557, 541-546;
69. b) G. Lv, R. Jin, W. Mai, L. Gao, Tetrahedron: Asymmetry 2008, 19, 2568-2572;
70. c) Y. Li, X.-Y. Liu, G. Zhao, Tetrahedron: Asymmetry 2006, 17, 2034-2039.
71. a) L. Zu, J. Wang, H. Li, W Wang, Org. Lett. 2006, 8, 3077-3079;
72. b) L. Zu, H. Li, J. Wang, X. Yu, W Wang, Tetrahedron Lett. 2006, 47, 5131-5134.
73. a) B. Ni, Q. Zhang, K. Dhungana, A. D. Headley, Org. Lett. 2009, 11, 1037-1040;
74. b) D. Q. Xu, Sh. P. Luo, Y. F. Wang, A. B. Xia, H. D. Yue, L. P. Wang, Zh. Y. Xu, Chem. Commun. 2007, 4393-4395;
75. c) L.-Y. Wu, Z.-Y. Yan, Y.-X. Xie, Y.-N. Niu, Y. M. Liang, Tetrahedron: Asymmetry 2007, 18, 2086-2090;
76. d) P. Li, L. Wang, M. Wang, Y. Zhang, Eur. J. Org. Chem. 2008, 1157-1160;
77. e) S. Luo, J. Li, L. Zhang, H. Xu, J.-P. Cheng, Chem. Eur. J. 2008, 14, 1273-1281;
78. f) S. Luo, X. Mi, L. Zhang, S. Liu, H. Xu, J.-P. Cheng, Angew. Chem. Int. Ed. 2006, 45, 3093-3097;
79. g) P. Li, L. Wang, Y. Zhang, G. Wang, Tetrahedron 2008, 64, 7633-7638;
80. h) D.-Q. Xu, B.-T. Wang, Sh.-P. Luo, H. D. Yue, L.-P. Wang, Zh.-Y. Xu, Tetrahedron: Asymmetry 2007, 18, 1788-1794;
81. i) B. Ni, Q. Zhang, A. D. Headley, Green Chem. 2007, 9, 737-739;
82. j) M. Lombardo, M. Chiarucci, A. Quintavalla, C. Trombini, Adv. Synth. Catal. 2009, 357, 2801-2806.
83. a) O. V. Maltsev, A. S. Kucherenko, S. G. Zlotin, Eur. J. Org. Chem. 2009, 5134-5137.
84. b) After submission of the present paper, the manuscript of Zeitler and Mager became available online, in which the synthesis of MeOPEG-supported Jørgensen catalyst with the (S) configuration of the C-2 pyrrolidine atom and its application for Michael addition of nitromethane to α,β-unsaturated aldehydes was reported: I. Mager, K. Zeitler, Org. Lett., DOI:10.1021/ol100166z.
85. K. Funabashi, M. Jaclimann, M. Kanai, M. Shibasaki, Angew. Chem. Int. Ed. 2003, 42, 5489-5492.
86. a) M. Lombardo, M. Chiarucci, A. Quintavalla, C. Trombini, Adv. Synth. Catal. 2009, 557, 2801-2806;
87. b) I. Fleischer, A. Pfaltz, Chem. Eur. J. 2010, 16, 95-99.
88. a) A. Carlone, M. Marigo, C. North, A. Landa, K. A. Jergensen, Chem. Commun. 2006, 4928-4930;
89. b) I. Ibrahem, W. Zou, Y. Xu, A. Cordova, Adv. Synth. Catal. 2006, 348, 211-222.
90. a) U Groselj, D. Seebach, D. M. Badine, W. B. Schweizer, A. K. Beck, I. Krossing, P. Klose, Y. Hayashi, T. Uchimaru, Helv. Chim. Acta 2009, 92, 1225-1259;
91. b) S. Lakhdar, T. Tokuyasu, H. Mayr, Angew. Chem. Int. Ed. 2008, 47, 8723-8726.
92. H. L. Ngo, K. LeCompte, L. Hargens, A. B. McEwen, Thermochim. Acta 2000, 357-358, 97-102.